Logo image of PPH

VANECK PHARMACEUTICAL ETF (PPH) Stock Price, Quote, News and Overview

NASDAQ:PPH - Nasdaq - US92189F6925 - ETF - Currency: USD

87.96  +0.49 (+0.56%)

After market: 87.6 -0.36 (-0.41%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to PPH. PPH was compared to 81 industry peers in the Automobile Components industry. PPH has an average financial health and profitability rating. PPH is valied quite expensively at the moment, while it does show a decent growth rate. Finally PPH also has an excellent dividend rating. These ratings would make PPH suitable for dividend investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

PPH had positive earnings in the past year.
PPH had a positive operating cash flow in the past year.
PPH had positive earnings in each of the past 5 years.
In the past 5 years PPH always reported a positive cash flow from operatings.
PPH Yearly Net Income VS EBIT VS OCF VS FCFPPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

Looking at the Return On Assets, with a value of 5.04%, PPH is in line with its industry, outperforming 50.62% of the companies in the same industry.
The Return On Equity of PPH (10.12%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 8.73%, PPH is in line with its industry, outperforming 49.38% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for PPH is in line with the industry average of 9.05%.
Industry RankSector Rank
ROA 5.04%
ROE 10.12%
ROIC 8.73%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
PPH Yearly ROA, ROE, ROICPPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 6.93%, PPH is in line with its industry, outperforming 53.09% of the companies in the same industry.
In the last couple of years the Profit Margin of PPH has remained more or less at the same level.
PPH's Operating Margin of 11.72% is in line compared to the rest of the industry. PPH outperforms 55.56% of its industry peers.
PPH's Operating Margin has been stable in the last couple of years.
PPH has a Gross Margin of 28.49%. This is comparable to the rest of the industry: PPH outperforms 48.15% of its industry peers.
PPH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.72%
PM (TTM) 6.93%
GM 28.49%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
PPH Yearly Profit, Operating, Gross MarginsPPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PPH is creating some value.
PPH has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, PPH has less shares outstanding
The debt/assets ratio for PPH is higher compared to a year ago.
PPH Yearly Shares OutstandingPPH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
PPH Yearly Total Debt VS Total AssetsPPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

PPH has an Altman-Z score of 3.52. This indicates that PPH is financially healthy and has little risk of bankruptcy at the moment.
PPH has a better Altman-Z score (3.52) than 76.54% of its industry peers.
PPH has a debt to FCF ratio of 3.42. This is a good value and a sign of high solvency as PPH would need 3.42 years to pay back of all of its debts.
With a Debt to FCF ratio value of 3.42, PPH perfoms like the industry average, outperforming 51.85% of the companies in the same industry.
PPH has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.31, PPH is in line with its industry, outperforming 45.68% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.42
Altman-Z 3.52
ROIC/WACC1.18
WACC7.4%
PPH Yearly LT Debt VS Equity VS FCFPPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

PPH has a Current Ratio of 1.76. This is a normal value and indicates that PPH is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.76, PPH is not doing good in the industry: 69.14% of the companies in the same industry are doing better.
PPH has a Quick Ratio of 1.11. This is a normal value and indicates that PPH is financially healthy and should not expect problems in meeting its short term obligations.
PPH has a Quick ratio of 1.11. This is in the lower half of the industry: PPH underperforms 69.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.11
PPH Yearly Current Assets VS Current LiabilitesPPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

4

3. Growth

3.1 Past

PPH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.42%.
The Earnings Per Share has been growing slightly by 1.64% on average over the past years.
The Revenue has decreased by -4.06% in the past year.
PPH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.41% yearly.
EPS 1Y (TTM)-5.42%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-5.56%
Revenue 1Y (TTM)-4.06%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.87%

3.2 Future

PPH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.51% yearly.
Based on estimates for the next years, PPH will show a small growth in Revenue. The Revenue will grow by 3.24% on average per year.
EPS Next Y35.36%
EPS Next 2Y23.07%
EPS Next 3Y17.51%
EPS Next 5YN/A
Revenue Next Year0.83%
Revenue Next 2Y2%
Revenue Next 3Y2.43%
Revenue Next 5Y3.24%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PPH Yearly Revenue VS EstimatesPPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
PPH Yearly EPS VS EstimatesPPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

PPH is valuated quite expensively with a Price/Earnings ratio of 28.65.
67.90% of the companies in the same industry are cheaper than PPH, based on the Price/Earnings ratio.
PPH's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.15.
Based on the Price/Forward Earnings ratio of 21.19, the valuation of PPH can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PPH indicates a slightly more expensive valuation: PPH is more expensive than 69.14% of the companies listed in the same industry.
PPH's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.60.
Industry RankSector Rank
PE 28.65
Fwd PE 21.19
PPH Price Earnings VS Forward Price EarningsPPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PPH is valued a bit more expensive than 67.90% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, PPH is valued a bit more expensive than the industry average as 64.20% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 24.62
EV/EBITDA 10.66
PPH Per share dataPPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PPH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PPH's earnings are expected to grow with 17.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.81
PEG (5Y)17.44
EPS Next 2Y23.07%
EPS Next 3Y17.51%

More info and screens

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.46%, PPH is a good candidate for dividend investing.
PPH's Dividend Yield is rather good when compared to the industry average which is at 4.43. PPH pays more dividend than 87.65% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, PPH pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.46%

5.2 History

The dividend of PPH is nicely growing with an annual growth rate of 7.84%!
PPH has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of PPH decreased in the last 3 years.
Dividend Growth(5Y)7.84%
Div Incr Years2
Div Non Decr Years2
PPH Yearly Dividends per sharePPH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

51.01% of the earnings are spent on dividend by PPH. This is a bit on the high side, but may be sustainable.
PPH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.01%
EPS Next 2Y23.07%
EPS Next 3Y17.51%
PPH Yearly Income VS Free CF VS DividendPPH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
PPH Dividend Payout.PPH Dividend Payout, showing the Payout Ratio.PPH Dividend Payout.PayoutRetained Earnings

More info and screens

VANECK PHARMACEUTICAL ETF

NASDAQ:PPH (6/30/2025, 8:00:01 PM)

After market: 87.6 -0.36 (-0.41%)

87.96

+0.49 (+0.56%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)04-24 2025-04-24
Earnings (Next)07-24 2025-07-24
Inst Owners39.91%
Inst Owner Change-2.91%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap62.08B
Analysts80
Price Target99.15 (12.72%)
Short Float %0.47%
Short Ratio6.06
Dividend
Industry RankSector Rank
Dividend Yield 4.46%
Yearly Dividend1.58
Dividend Growth(5Y)7.84%
DP51.01%
Div Incr Years2
Div Non Decr Years2
Ex-Date04-01 2025-04-01 (0.5245)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.64%
PT rev (3m)-5.83%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.7%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.5%
Valuation
Industry RankSector Rank
PE 28.65
Fwd PE 21.19
P/S 1.95
P/FCF 24.62
P/OCF 12.23
P/B 2.85
P/tB 3.88
EV/EBITDA 10.66
EPS(TTM)3.07
EY3.49%
EPS(NY)4.15
Fwd EY4.72%
FCF(TTM)3.57
FCFY4.06%
OCF(TTM)7.19
OCFY8.18%
SpS45.1
BVpS30.89
TBVpS22.68
PEG (NY)0.81
PEG (5Y)17.44
Profitability
Industry RankSector Rank
ROA 5.04%
ROE 10.12%
ROCE 11.13%
ROIC 8.73%
ROICexc 10.35%
ROICexgc 13.02%
OM 11.72%
PM (TTM) 6.93%
GM 28.49%
FCFM 7.92%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ROICexc(3y)10.37%
ROICexc(5y)9.81%
ROICexgc(3y)12.78%
ROICexgc(5y)12.13%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexcg growth 3Y-1.65%
ROICexcg growth 5Y0.27%
ROICexc growth 3Y-2.16%
ROICexc growth 5Y0.21%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.42
Debt/EBITDA 1.12
Cap/Depr 110.04%
Cap/Sales 8.02%
Interest Coverage 12.7
Cash Conversion 83.87%
Profit Quality 114.33%
Current Ratio 1.76
Quick Ratio 1.11
Altman-Z 3.52
F-Score5
WACC7.4%
ROIC/WACC1.18
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.42%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-5.56%
EPS Next Y35.36%
EPS Next 2Y23.07%
EPS Next 3Y17.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.06%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.87%
Revenue Next Year0.83%
Revenue Next 2Y2%
Revenue Next 3Y2.43%
Revenue Next 5Y3.24%
EBIT growth 1Y-7.52%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year66.93%
EBIT Next 3Y23.28%
EBIT Next 5Y17.83%
FCF growth 1Y-29.4%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-17.99%
OCF growth 3Y14.27%
OCF growth 5Y5.48%